Weight Effect of Current and Experimental Drugs for Diabetes Mellitus

Springer Science and Business Media LLC - Tập 2 Số 1 - Trang 33-47 - 2003
Jonathan Q. Purnell1, Christian Weyer2
1Division of Endocrinology, Diabetes and Clinical Nutrition, L607, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon, 97201, USA
2Amylin Pharmaceuticals Inc., San Diego, California, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

1993, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401

1996, Diabetes, 45, 1289, 10.2337/diab.45.10.1289

1998, Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6

1998, Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8

Felig, 1979, N Engl J Med, 301, 1004

Bolli, 1999, Diabetologia, 42, 1151, 10.1007/s001250051286

DeFronzo, 1999, Ann Intern Med, 131, 281, 10.7326/0003-4819-131-4-199908170-00008

1988, Diabetes Care, 11, 567, 10.2337/diacare.11.7.567

2001, Diabetes Care, 24, 1711, 10.2337/diacare.24.10.1711

Purnell, 1998, JAMA, 280, 140, 10.1001/jama.280.2.140

Reichard, 1994, Diabetes, 43, 313, 10.2337/diab.43.2.313

Henry, 1993, Diabetes Care, 16, 21, 10.2337/diacare.16.1.21

Riddle, 1998, Diabetes Care, 21, 1052, 10.2337/diacare.21.7.1052

Gottlieb, 2000, Diabetes, 49, A109

DeFronzo, 1995, N Engl J Med, 333, 541, 10.1056/NEJM199508313330902

Lins, 1988, Acta Med Scand, 223, 171, 10.1111/j.0954-6820.1988.tb15783.x

Ratner, 2002, Diabetes Technol Ther, 4, 51, 10.1089/15209150252924094

Rosenstock, 1996, Diabetes Care, 19, 1194, 10.2337/diacare.19.11.1194

Simonson, 1997, Diabetes Care, 20, 597, 10.2337/diacare.20.4.597

Weyer, 2001, Curr Pharm Des, 7, 1353, 10.2174/1381612013397357

Young, 1997, Curr Opin Endocrinol Diab, 4, 282, 10.1097/00060793-199708000-00006

Edelman, 2002, Diabetes Technol Ther, 4, 175, 10.1089/15209150260007390

Lutz, 2001, Int J Obes Relat Metab Disord, 25, 1005, 10.1038/sj.ijo.0801664

Rushing, 2001, Endocrinology, 142, 5035, 10.1210/endo.142.11.8593

Luzi, 1989, Am J Physiol, 257, E241

Bruce, 1988, Diabetes, 37, 736, 10.2337/diab.37.6.736

Saltiel, 1996, Diabetes, 45, 1661, 10.2337/diab.45.12.1661

Spiegelman, 1998, Diabetes, 47, 507, 10.2337/diabetes.47.4.507

Iwamoto, 1996, Diabetes Care, 19, 151, 10.2337/diacare.19.2.151

William-Olsson, 1985, Acta Med Scand Suppl, 706, 1

Cooper, 1987, Proc Natl Acad Sci U S A, 84, 8628, 10.1073/pnas.84.23.8628

Koda, 1992, Lancet, 339, 1179, 10.1016/0140-6736(92)90785-2

Kolterman, 1996, Diabetologia, 39, 492, 10.1007/BF00400683

Thompson, 1997, Diabetes, 46, 632, 10.2337/diabetes.46.4.632

Thompson, 1997, Diabet Med, 14, 547, 10.1002/(SICI)1096-9136(199707)14:7<547::AID-DIA390>3.0.CO;2-U

Kolterman, 1995, Diabetes Care, 18, 1179, 10.2337/diacare.18.8.1179

Thompson, 1998, Diabetes Care, 21, 987, 10.2337/diacare.21.6.987

Fineman, 1998, Diabetologia, 41, A167

Nyholm, 1999, Metabolism, 48, 935, 10.1016/S0026-0495(99)90232-9

Kong, 1997, Diabetologia, 40, 82, 10.1007/s001250050646

Kong, 1998, Diabetologia, 41, 577, 10.1007/s001250050949

Rushing, 2000, Endocrinology, 141, 850, 10.1210/endo.141.2.7378

Rushing, 2000, Horm Metab Res, 32, 62, 10.1055/s-2007-978590

Drucker, 2001, Endocrinology, 142, 521, 10.1210/endo.142.2.7983

Perfetti, 2000, Eur J Endocrinol, 143, 717, 10.1530/eje.0.1430717

Baron, 2002, Curr Drug Targets Immune Endocr Metab Disord, 2, 63, 10.2174/1568005310202010063

Rachman, 1997, Diabetologia, 40, 205, 10.1007/s001250050664

Zander, 9, Lancet 2 Mar, 359, 824, 10.1016/S0140-6736(02)07952-7